110
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

SIMULTANEOUS DETERMINATION OF GLIMEPIRIDE AND ATORVASTATIN IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY: APPLICATION TO PHARMACOKINETIC STUDY

, , , , &
Pages 2420-2432 | Published online: 18 Nov 2011
 

Abstract

A simple and sensitive high performance liquid chromatographic method for simultaneous quantification of glimepiride (GMP) and atorvastatin (ATN) in human serum was developed and validated. GMP, ATN, and internal standard (IS), pioglitazone (PG) were extracted into dichloromethane and methanol solvent system and separated using an isocratic mobile phase on an Inertsil C18 column. The eluent was monitored by UV detector at 230 nm. The linearity range of proposed method was 1–1600 ng mL−1 for each analyte. The retention times for GMP, ATN, and IS were found to be 9.8, 6.92, and 7.96 min, respectively. The intra-day and inter-day coefficient of variation and percentage error values of the assay method were less than 15% and mean recovery was more than 96, 93, and 95% for GMP, ATN, and IS, respectively, and the method was found to be precise, accurate, and specific. The method was successfully applied for pharmacokinetic study of GMP and ATN after oral administration to patients. The CMax, TMax, and AUC0–12 of GMP and ATN were found to be 355.3 ng mL−1, 3.1 hr, 2167.5 ng h mL−l and 12.6 ng mL−1, 2.6 hr, 80.8 ng h mL−l, respectively.

ACKNOWLEDGMENTS

The authors thank Dr. Reddy's Laboratories, Hyderabad, India for providing gift samples of glimepiride, atorvastatin, and pioglitazone. The authors also thank Gandhi Hospital, Hyderabad, India for providing facilities to carry out the pharmacokinetic study.

Notes

a Values are mean ± S.D (n = 3).

b After 12 hr at room temperature.

c After three freeze thaw cycles.

d After 30 days at −20°C.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.